iECURE
  • Home
  • About
    • Our Story
    • Leadership
    • Board of Directors
    • Team
    • Investors
  • Approach
    • In Vivo Gene Insertion
    • Penn Collaboration
  • Programs
    • Overview
    • Pipeline
    • Urea Cycle Disorders
  • Careers
    • Mission
    • Culture
    • Work With Us
  • News
  • Contact
  • Menu Menu

https://www.businessinsider.com/list-healthcare-startups-that-will-take-off-in-2022-according-to-investors-2021-11#iecure-14

December 1, 2021/in in the news, news/by Emily Hennes
https://iecure.com/wp-content/uploads/insider.svg 52 280 Emily Hennes /wp-content/uploads/iEcure_logo.png Emily Hennes2021-12-01 19:30:422021-12-30 12:41:0634 healthcare and biotech startups that are set to take off in 2022, according to top investors

https://technical.ly/philly/2021/09/10/iecure-gene-editing-series-a/

December 1, 2021/in in the news, news/by Emily Hennes
https://iecure.com/wp-content/uploads/logo-tm.svg 52 280 Emily Hennes /wp-content/uploads/iEcure_logo.png Emily Hennes2021-12-01 19:29:062021-12-29 20:47:04Penn gene editing spinout iECURE just raised a $50M Series A

https://www.forbes.com/sites/aayushipratap/2021/09/09/this-startup-just-raised-50-million-to-deliver-gene-therapies-for-rare-diseases/?sh=74e41580282c

September 9, 2021/in in the news, news/by David Anderson
https://iecure.com/wp-content/uploads/forbes_logo_white.svg 50 198 David Anderson /wp-content/uploads/iEcure_logo.png David Anderson2021-09-09 08:00:322022-02-04 18:51:00This Startup Just Raised $50 Million To Deliver Gene Therapies For Rare Diseases

https://medcitynews.com/2021/09/genetic-meds-pioneer-james-wilson-has-a-new-startup-this-time-in-gene-editing/

December 1, 2021/in in the news, news/by Emily Hennes
https://iecure.com/wp-content/uploads/logo-MedCity.svg 52 280 Emily Hennes /wp-content/uploads/iEcure_logo.png Emily Hennes2021-12-01 19:29:522021-12-29 20:44:37Genetic meds pioneer James Wilson has a new startup, this time in gene editing

https://cen.acs.org/pharmaceuticals/gene-therapy/Jim-Wilson-launches-liver-disease/99/i33

December 1, 2021/in in the news, news/by Emily Hennes
https://iecure.com/wp-content/uploads/cen-logo.svg 52 280 Emily Hennes /wp-content/uploads/iEcure_logo.png Emily Hennes2021-12-01 19:26:302021-12-29 21:00:35Jim Wilson launches liver disease gene-editing company iECURE with $50 million

https://www.fiercebiotech.com/biotech/iecure-emerges-50m-series-a-to-develop-gene-therapies-for-liver-disorders-jim-wilson-s-penn

December 1, 2021/in in the news, news/by Emily Hennes
https://iecure.com/wp-content/uploads/logo-fiercebiotech.svg 52 280 Emily Hennes /wp-content/uploads/iEcure_logo.png Emily Hennes2021-12-01 19:25:272021-12-29 21:02:46iECURE emerges with $50M to search for ‘holy grail’ and ‘untapped frontier’ of gene editing

https://endpts.com/the-tachi-yamada-legacy-tree-continues-to-grow-with-a-new-gene-editing-biotech-from-jim-wilson/

September 9, 2021/in in the news, news/by Emily Hennes
https://iecure.com/wp-content/uploads/endpoint-news.svg 52 280 Emily Hennes /wp-content/uploads/iEcure_logo.png Emily Hennes2021-09-09 08:00:552021-12-30 15:38:36The Tachi Yamada legacy tree continues to grow with a new gene editing biotech from Jim Wilson
  • Home
  • About
    • Our Story
    • Leadership
    • Board of Directors
    • Team
    • Investors
  • Approach
    • In Vivo Gene Insertion
    • Penn Collaboration
  • Programs
    • Overview
    • Pipeline
    • Urea Cycle Disorders
  • Careers
    • Mission
    • Culture
    • Work With Us
  • News
  • Contact

Copyright 2023 – iECURE

Scroll to top